ClinicalTrials.Veeva

Menu

The Analgesic Efficacy of Oxycodone Hydrochloride Versus Fentanyl After Total Hip Arthroplasty:

A

Al-Azhar University

Status and phase

Completed
Phase 4

Conditions

Total Hip Arthroplasty
The Analgesic Efficacy

Treatments

Drug: propofol, rocuronium and fentanyl

Study type

Interventional

Funder types

Other

Identifiers

NCT05602519
IRB 00012367-22-010-005

Details and patient eligibility

About

Oxycodone showed similar or superior analgesic effects than fentanyl and was proposed as an alternative for fentanyl for pain control in the postoperative period. However, it was mainly directed to control visceral pain, due to the mediation of analgesic effects by the kappa receptors. However, few studies compared the oxycodone to fentanyl for postoperative pain relief in patients undergoing total hip arthroplasty (replacement). Therefore, we established this randomized study to compare the efficacy of oxycodone and fentanyl for relief of postoperative pain after total hip arthroplasty (replacement).

Enrollment

72 patients

Sex

All

Ages

28 to 62 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients aged 28-62 years old,
  • Both genders, American Society of Anesthesiologists (ASA) physical status classification I or II who scheduled for elective total hip surgery.

Exclusion criteria

  • Patients with history of any kind of drug allergy.
  • drug abuse.
  • psychological or other emotional problems,
  • renal and hepatic chronic disease.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

72 participants in 2 patient groups

Group fentanyl
Active Comparator group
Description:
Patients will receive 50 ug of fentanyl 20 min before the end of surgery.
Treatment:
Drug: propofol, rocuronium and fentanyl
Group oxycodone
Active Comparator group
Description:
Patients will receive 4 mg of oxycodone 20 min before the end of surgery.
Treatment:
Drug: propofol, rocuronium and fentanyl

Trial contacts and locations

1

Loading...

Central trial contact

Neveen A. Kohaf, Ph.D

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems